|
"yao cc"的相關文件
顯示項目 1-10 / 26 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
| 中山醫學大學 |
2021 |
Concurrent Cholecystectomy Is Associated with a Lower Risk of Recurrence after Curative Resection in Early-Stage Hepatocellular Carcinoma: A 10 Year Observational Single-Center Study
|
Chen, YS; Yang, SY; Wang, PM; Wang, CC; Yong, CC; Chen, DW; Liu, YW; Chuang, CH; Huang, PY; Yao, CC; Lin, YP; Tsai, MC |
| 中山醫學大學 |
2021 |
Correspondence to proton pump inhibitors and risk of colorectal cancer
|
Dong, C; Lee, YH; Tan, TY; Yao, CC; Wei, JCC |
| 中山醫學大學 |
2013 |
The effects of perceived stress and life style leading to breast cancer.
|
Wang L;Liao WC;Tsai CJ;Wang LR;Mao IF;Chen CC;Kao PF;Yao CC |
| 中山醫學大學 |
2010 |
HER2 gene amplification in primary mucinous ovarian cancer: a potential therapeutic target.
|
Han, CP; Hsu, JD; Yao, CC; Lee, MY; Ruan, A; Tyan, YS; Yang, SF; Chiang, H |
| 中山醫學大學 |
2010 |
The murine monoclonal antibody anti-cytokeratin CAM 5.2 is specific for intracellular cytokeratin 8, not cytokeratin 18.
|
Cheng, WC; Hsu, JD; Yao, CC; Han, CP |
| 中山醫學大學 |
2010 |
Anti-Cytokeratin CAM5.2 (BD) does not act as a substitute of the CK8/18 monoclonal antibody. Comment on: 'Expression of c-MET, low-molecular-weight cytokeratin, matrix metalloproteinases-1 and -2 in spinal chordoma'. Histopathology 2009; 54; 607-613.
|
Hsu, JD; Yao, CC; Yuan, CC; Lai, CR; Ting, LT; Li, YJ; Han, CP |
| 中山醫學大學 |
2010 |
True cytokeratin 8/18 immunohistochemistry is of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
|
Hsu, JD; Yao, CC; Lee, MY; Kok, LF; Wang, PH; Tyan, YS; Han, CP |
| 中山醫學大學 |
2010 |
Distinguishing between primary endocervical and endometrial adenocarcinomas: is a 2-marker (Vim/CEA) panel enough?
|
Liao, CL; Hsu, JD; Lee, MY; Kok, LF; Li, YJ; Wang, PH; Yao, CC; Han, CP |
| 中山醫學大學 |
2010 |
Anti-cytokeratin CAM5.2 is not a monoclonal antibody against cytokeratin 8/18.
|
Hsu, JD; Yao, CC; Han, LW; Han, CP |
| 中山醫學大學 |
2010 |
Laparoscopic primary closure of common bile duct combined with percutaneous cholangiographic drainage for treating choledocholithiasis.
|
Huang, SM; Yao, CC; Cheng, YW; Chen, LY; Pan, H; Hsiao, KM; Yang, MD; Wu, CW; Lui, WY; Lai, TJ |
顯示項目 1-10 / 26 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
|
